Nonetheless, whether BBR impacts NLRP3 inflammasome activation, the subsequent pyroptosis in NASH, and the potential mechanism whereby these occur, remain unclear. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.